Wells Fargo’s Zealand Pharma A/S American Depositary Shares ZEAL Stock Holding History

Wells Fargo’s Portfolio ZEAL Stock Details ZEAL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100	Closed	-$1K	–	7859
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	6706
2022 Q1	$2K	Hold	100	–	–	﹤0.01%	6735
2021 Q4	$2K	Hold	100	–	–	﹤0.01%	6941
2021 Q3	$3K	Hold	100	–	–	﹤0.01%	6536
2021 Q2	$3K	Hold	100	–	–	﹤0.01%	6502
2021 Q1	$3K	Buy	+100	New	+$3.37K	﹤0.01%	6607
2017 Q4	–	Sell	-75	Closed	-$1K	–	6607
2017 Q3	$1K	Buy	+75	New	+$1.41K	﹤0.01%	6258

Other funds holding ZEAL

TimeScale Financial Danvers, Massachusetts $463M AUM 12.48% 1-Year Est. Return

Wells Fargo's ZEAL Position: Q3 2022 in Review

Wells Fargo sold out of Zealand Pharma A/S American Depositary Shares (ZEAL) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

Wells Fargo first reported a position in ZEAL in Q3 2017 and held it in 7 quarters. The position peaked at $3K in Q3 2021. 1 fund tracked by Wall St. Rank holds ZEAL as of Q3 2022.

Wells Fargo reported no remaining Zealand Pharma A/S American Depositary Shares position as of Q3 2022 after selling out during the quarter.
Wells Fargo sold 100 Zealand Pharma A/S American Depositary Shares shares in Q3 2022, an estimated $1K.
Wells Fargo first reported a position in Zealand Pharma A/S American Depositary Shares in Q3 2017 and held it in 7 quarters.
Wells Fargo's Zealand Pharma A/S American Depositary Shares position peaked at $3K in Q3 2021.
1 fund tracked by Wall St. Rank held Zealand Pharma A/S American Depositary Shares as of Q3 2022.

Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.